Fexaramine Inhibits Receptor Activator of Nuclear Factor-κB Ligand-induced Osteoclast Formation via Nuclear Factor of Activated T Cells Signaling Pathways

BACKGROUND: Osteoclasts are bone resorbing cells and are responsible for bone erosion in diseases as diverse as osteoporosis, periodontitis, and rheumatoid arthritis. Fexaramine has been developed as an agonist for the farnesoid X receptor (FXR). This study investigated the effects of fexaramine on...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Ting, Kim, Na-Young, Yim, Mijung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Bone and Mineral Research 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5734945/
https://www.ncbi.nlm.nih.gov/pubmed/29259959
http://dx.doi.org/10.11005/jbm.2017.24.4.207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5734945/
https://www.ncbi.nlm.nih.gov/pubmed/29259959
http://dx.doi.org/10.11005/jbm.2017.24.4.207

Ejemplares similares